[The treatment of patients with recurrent pulmonary tuberculosis]

N S Strakhov, V I Zozuliak, M I Strutinskiĭ

Vrachebnoe Delo

|August 1, 1990

Abstract:

A study is presented of the treatment efficacy of 96 patients with destructive forms of recurrent pulmonary tuberculosis depending on the use of different pathogenetic agents. It was found that in group receiving pathogenetic treatment closure of the destruction caverns increased to 73.7% (53% in the control group) and healing time reduced.

Related Experiment Videos

[The treatment of patients with recurrent pulmonary tuberculosis]

Related Concept Videos

[The role of and changes in the copper and zinc levels and the activity of their related metalloenzymes in the blood of patients with destructive pulmonary tuberculosis during chemotherapy].

[Effectiveness of chemotherapy of patients with newly detected destructive pulmonary tuberculosis living in rural areas].

A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.

Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.

Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

Is there a role for palliative care in CAR T-cell therapy?

Synergistic Antitumor Effects and Reduced Systemic Toxicity of Berberine Chloride Combined With Cisplatin in a Female BALB/c Mouse Xenograft Model.

Related Experiment Videos

[The treatment of patients with recurrent pulmonary tuberculosis]

Abstract:

Related Concept Videos

Related Articles